Arcutis Biotherapeutics, Inc. (ARQT) NASDAQ
21.17
+0.51(+2.47%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 3.69B |
| Enterprise Value | 3.66B |
| P/E Ratio | -1,152.63 |
| PEG Ratio | -2.35 |
| Price/Sales Ratio | 6.37 |
| Price/Book Ratio | 14.44 |
| Enterprise/Revenue | 6.32 |
| Enterprise/EBITDA | 215.09 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | -0.01 |
| Operating Margin | 0.01 |
Management Effectiveness
| Return On Assets | -0.01 |
| Return On Equity | -0.01 |
Income Statement
| Revenue | 376.07M |
| Revenue/Share | 3.21 |
| Gross Profit | 339.38M |
| EBITDA | 2.48M |
| Net Income | -16.14M |
| Diluted EPS | -0.13 |
Balance Sheet
| Total Cash | 224M |
| Total Cash/Share | 1.73 |
| Total Debt | 13.2M |
| Total Debt/Equity | 0.07 |
| Current Ratio | 2.68 |
| Book Value Per Share | 1.47 |
Price History
| 52-Week Change | 56.47 |
| 52-Week High | 31.77 |
| 52-Week Low | 12.72 |
| Moving Average 50 Days | 23.43 |
| Moving Average 200 Days | 23.04 |
Statistics
| Average Volume | 1.38M |
| Shares Outstanding | 125.08M |
| % Held by Institutions | 101.15 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
